Borders and Southern unable to reach targets for Stebbing well
AIM-listed oil and gas group Borders and Southern has found very strong gas shows in the Tertiary section of the 61/25-1 well (Stebbing) but couldn't reach lower targets due to 'anomalous pressure conditions'.
AIM-listed oil and gas group Borders and Southern has found very strong gas shows in the Tertiary section of the 61/25-1 well (Stebbing) but couldn't reach lower targets due to 'anomalous pressure conditions'.
"It is very disappointing not to have reached all the potential reservoir targets in this well. The geological and engineering data will now be reviewed in detail in order to understand the complexities of this prospect," the company said in a statement on Monday.
Within the Tertiary section, analysis of the wireline logs suggest an interval (2,500-2,651m) of thin bedded siltstones and claystones with a net-to-gross of 36% and an average porosity of 19%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"Due to the thin bedded character of this sequence it was not possible to obtain a clear indication of the fluid type or saturation. The geophysical anomalies identified on seismic are coincident with this zone containing hydrocarbons. Our initial assessment is that this upper target is unlikely to be commercial although further technical evaluation is required."
Borders & Southern now intends to plug and abandon the well in line with regulatory requirements and assign the rig to Falkland Oil and Gas.
BC
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published